Developer docs
API playgroundTry for free, no card

Search company profiles

MagView

Full company profile

uuid000adeb

Namestring
MagView
Legal namestring
MagView
Websiteurl
magview.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

MagView is a privately held mammography information system (MIS) software company founded in 1990 and originally developed for the American College of Radiology as the first BI-RADS structured reporting system. The company provides a modular software platform for U.S. breast imaging centers covering patient tracking, structured radiology reporting, MQSA compliance, workflow automation, patient navigation, and breast cancer risk assessment. Its core architecture combines the MagView MIS platform with the proprietary MagLink integration suite (supporting HL7, DICOM, and web APIs), the MagTAC interface monitor, and the Luminary Risk module for high-risk screening, which integrates the Tyrer-Cuzick v8.0 (IBIS) risk model alongside the FDA-authorized Clairity Breast AI image-based risk assessment and Myriad Genetics' hereditary cancer testing. MagView serves over 2,500 breast imaging facilities in the United States, with stated penetration of approximately 50% of the top 25 cancer hospitals, and is the only vendor with full NQMBC 2.0 certified software.

The company operates an enterprise direct-sales go-to-market motion with "Request a Demo" CTAs and quote-based pricing, targeting cancer centers, academic medical centers, large health systems, outpatient imaging providers, VA hospitals, and private radiology practices. Revenue is generated primarily through annual subscription licenses for the core MIS and modular add-ons, supplemented by implementation, configuration, training, and integration professional services. Notable named customers include CARTI Cancer Center, University of Virginia, MemorialCare Health System, SimonMed Imaging, Rayus Radiology, Houston Methodist, Penn State Health, Denver Health, Emory Winship Cancer Institute, and Steinberg Diagnostic Medical Imaging (SDMI). Long-standing technology partnerships include Hologic (co-developer of the Unifi EQUIP quality compliance software), Epic, Nuance, and the National Consortium of Breast Centers (NCoBC), and recent strategic collaborations include Clairity and Myriad Genetics to deliver an integrated AI and genetic risk assessment platform launched in November 2025.

The company is headquartered in Fulton, Maryland, employs 51-100 people, and is privately held with no disclosed parent company, outside investors, or funding rounds. MagView is also beginning to extend beyond breast imaging with a referenced Lung Screening offering (lungview.com), indicating modest adjacent-vertical expansion.

Short descriptiontext

MagView is a privately held mammography information system software company founded in 1990 that serves over 2,500 U.S. breast imaging facilities with workflow, reporting, risk assessment, and MQSA compliance tools, including the Luminary Risk module with FDA-authorized AI.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersFulton, United States
HQ citystring
Fulton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mammography information systems, breast imaging workflow software, BI-RADS structured reporting, MQSA compliance software, breast cancer risk assessment
Industry3 codes
PRIMARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code2 codes
  • Software Publishers513210
  • Software Publishers5132
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Mammography Information Systems / Breast Imaging Workflow Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Mammography Information System Software Licenses
TypeSubscription Recurring
Description

MagView provides mammography tracking and reporting software to breast imaging centers, likely through annual or multi-year software licenses with implementation and support services included.

magview.com
2Risk Assessment Software (Luminary Risk)
TypeSubscription Recurring
Description

High-risk breast cancer screening software sold to imaging facilities and healthcare providers for personalized risk assessment and patient management.

magview.com
3Professional Services and Implementation
TypeProfessional Services
Description

Implementation, configuration, and training services for breast imaging facilities deploying MagView software solutions.

magview.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others
Pricing details1 tier
1Enterprise Healthcare Software - Quote-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

No publicly listed pricing. The company targets healthcare facilities of various sizes including enterprise health systems, cancer centers, and private practices through direct sales with demo requests. Pricing likely varies based on facility size, number of modules, and implementation scope.

magview.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Luminary Risk
Description

High-risk breast cancer screening software for identifying and managing high-risk patients with support for unique workflows and facilities of any size.

magview.com
+3 more records
Core offering1 text field

MagView sells a mammography information system (MIS) software platform that helps breast imaging centers automate patient tracking, perform BI-RADS structured radiology reporting, manage MQSA compliance, run patient navigation, and conduct high-risk breast cancer risk assessment via its Luminary Risk module. The platform is sold primarily through direct enterprise sales to U.S. breast imaging centers, cancer centers, hospital systems, and radiology practices on a subscription/annual license basis, with implementation and support services included.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 2,500 breast imaging facilities rely on MagView software
+3 more records
Product overview1 text field

MagView is a mammography information system (MIS) — a comprehensive, modular software platform for breast imaging centers. The core MagView platform provides patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics, upon which specialized modules are built. Key modules include: Mammography Tracking Software (automated patient tracking and follow-up), Radiology Reporting Software (BI-RADS structured and dictation-based reporting), Workflow Solutions (TechPad, patient experience tools), Compliance & Analytics (MQSA compliance), and Patient Navigation (care continuum tracking). The product suite is anchored by Luminary Risk — MagView's breast cancer risk assessment platform that integrates Tyrer-Cuzick and other risk models, and which now incorporates Clairity Breast (FDA-authorized AI image-based risk assessment) and connects to Myriad Genetics MyRisk hereditary cancer testing. A free online Tyrer-Cuzick Risk Calculator is also offered for patient-facing use. The platform serves more than 2,500 facilities across the United States.

Product and service14 records
1MagView Mammography Information System
CategoryMammography Information System / Core Platform
Description

Core mammography information system (MIS) platform for breast imaging centers providing patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics. Sold to U.S. breast imaging centers, cancer centers, and radiology practices via direct enterprise sales.

2Luminary Risk
CategoryBreast Cancer Risk Assessment Software
Description

High-risk breast cancer risk assessment platform integrating the Tyrer-Cuzick v8.0 (IBIS) risk model and Clairity Breast AI image-based risk assessment, with automated risk scoring, care pathway recommendations, and patient communication. Available in two versions: Luminary Risk for Breast Imaging and Luminary Risk for Providing Physicians.

3Clairity Breast AI Image-Based Risk Assessment
CategoryAI-Powered Risk Assessment
Description

First and only FDA-authorized AI image-based breast cancer risk assessment that analyzes mammogram images to estimate a woman's five-year risk of developing breast cancer, now natively available within the Luminary Risk workflow software for breast imaging facilities.

4Tyrer-Cuzick (IBIS) Risk Calculator
CategoryBreast Cancer Risk Assessment Tool
Description

Online breast cancer risk assessment tool using the Tyrer-Cuzick v8 (IBIS) risk model that estimates a patient's chance of developing breast cancer based on personal and family health history. Free non-clinical version for patients; clinical licenses available for facilities.

5Mammography Tracking Software
CategoryPatient Tracking Module
Description

Automated patient tracking module that ensures no patient falls through the cracks with automated lay letters, reminders, and actionable reports. Includes automated BI-RADS, breast density, risk score, and recommendation extraction from dictated reports and MQSA compliance tracking. Sold to breast imaging centers as part of the MagView platform.

6Radiology Reporting Software
CategoryRadiology Reporting Module
Description

Flexible BI-RADS reporting module for breast radiologists with one-click negatives for screening mammograms, smart data capture from dictated reports, voice dictation integration, and full patient visibility including risk scores and history. Sold as part of the MagView platform.

7Workflow Solutions
CategoryWorkflow Module
Description

Comprehensive breast imaging facility workflow solution including TechPad mobile workstation, integrated history collection, patient status board, advanced breast diagram, and integrations with EMR, RIS, PACS, and dictation systems. Sold to breast imaging facilities.

8Compliance & Analytics
CategoryCompliance & Analytics Module
Description

MQSA compliance and analytics module that streamlines certification and compliance for breast imaging centers. Includes quality assurance dashboard, audit support, document management, real-time alerts, built-in MQSA reporting tools, outcome statistics calculations, and automated oversight of the EQUIP process. Sold to breast imaging facilities.

9Patient Navigation
CategoryPatient Navigation Module
Description

Cancer patient navigation system that tracks patients through the continuum of care from imaging through treatment and beyond. Features user-defined navigation worklists, automated reminders, overdue follow-up flags, integrated imaging and pathology results, and customizable stages based on NCBC Navigation Matrix. Sold to breast centers.

10Patient Experience Tools
CategoryPatient Experience Module
Description

Suite of patient-facing tools including automated text messaging reminders, Patient History Portal (HIPAA-compliant online pre-visit questionnaires), Patient Tablet Module (in-office electronic forms with 95% adoption at some facilities), and Patient Results Portal (HIPAA-compliant access to lay letters). Sold to breast imaging centers.

11TechPad Mobile Workstation
CategoryMobile Workflow Hardware-Software Solution
Description

Mobile technologist workflow tool that untethers technologists from desktop workstations, allowing them to move freely with patients, receive instant radiologist feedback, update patient status immediately, and reduce waiting time. Sold to breast imaging facilities.

12MagLink Integration Suite
CategoryIntegration Platform
Description

First and only vendor-created integration suite enabling complex workflows via HL7, DICOM, and web APIs. Custom-written interfaces enable seamless connection with EHR, RIS, PACS, dictation systems, and other breast imaging technology systems. Sold as part of the MagView platform.

13MagTAC Interface Monitor
CategorySystem Monitoring Tool
Description

Real-time monitoring system that verifies proper functioning of database and interfaces, promptly alerting support team for minimal interface downtimes. Sold as part of the MagView platform to breast imaging facilities.

14Integrated AI and Genetic Risk Platform
CategoryIntegrated Risk Assessment Platform
Description

Unified AI and genetic risk assessment platform combining Clairity Breast AI image-based risk assessment, Myriad's MyRisk Hereditary Cancer Test with RiskScore, and MagView's Luminary Risk workflow software for comprehensive personalized breast cancer risk assessment. Available through MagView's platform to 2,500+ U.S. breast imaging facilities.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-25
Description

Strategic collaboration to integrate Myriad's genetic testing capabilities (MyRisk Hereditary Cancer Test with RiskScore) with MagView's Luminary Risk platform for comprehensive breast cancer risk assessment. The integrated platform combines Clairity Breast AI image-based risk, Myriad's genetic testing, and MagView's workflow software into a unified tool for personalized breast health management.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-25
Description

Integration partnership to bring Clairity Breast, the first and only FDA-authorized AI image-based breast cancer risk assessment, into MagView's Luminary Risk platform. Clairity Breast analyzes mammogram images to estimate five-year breast cancer risk, identifying high-risk women who may be missed by traditional models.

3Know Your Lemons Foundation
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-11-05
Description

Partnership to help breast centers improve screening rates by combining MagView's workflow solutions with Know Your Lemons' innovative breast health education using a simple, lemon-based visual system to teach signs of breast cancer.

magview.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

Long-standing tight integration partnership with Hologic, leaders in breast imaging technology. Jointly developed the award-winning Unifi EQUIP software solution released in 2019 for mammography quality compliance.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnership enabling seamless data exchange between MagView's mammography software and Epic's electronic health record system, commonly used by many breast centers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MagView was originally founded by the ACR and developed as the first BI-RADS structured reporting system. Ongoing collaboration for MQSA compliance, BI-RADS standards, and breast imaging excellence.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Virtual care partnership providing patients access to board-certified genetic counselors from DNA Visit for hereditary cancer testing consultation through MagView's patient portal.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCoBC elected MagView to lead development of the NQMBC 2.0 Vendor Certification Program. MagView is the first and remains the only certified software supporting NQMBC 2.0.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hologic is a leading breast imaging hardware OEM and a strategic partner of MagView (co-developed Unifi EQUIP). As a broad incumbent, it offers SecurView diagnostic workstations and increasingly competes at the workflow layer via its own mammography software stack.

TypeEmerging player
Description

Koios Medical offers AI decision-support for breast and thyroid ultrasound, with breast applications that overlap with MagView's risk-assessment and reporting modules for downstream supplemental imaging.

TypeEmerging player
Description

CureMetrix develops AI-based mammography CADt and triage algorithms that integrate into breast imaging reporting workflows. It competes at the AI image-based risk and detection layer that MagView addresses via Clairity.

4PenRad Technologies
TypeDirect peer
Description

PenRad is a direct competitor to MagView, providing mammography reporting, patient tracking, and MQSA/EQUIP compliance software to breast imaging centers across the United States. It overlaps most closely with MagView's core MIS and reporting modules.

TypeEmerging player
Description

iCAD offers ProFound AI for breast cancer detection and risk assessment, integrating into mammography reporting workflows. It competes with MagView's Clairity-integrated Luminary Risk on AI image-based risk and detection.

TypeEmerging player
Description

Densitas provides AI-driven breast density assessment and quality assurance tools integrated with mammography reporting workflows. It overlaps with MagView's density extraction and risk modules and represents a more specialized AI-native competitor.

TypeBroad incumbent
Description

Epic's Beaker LIS and imaging modules are integrated with MagView via MagLink but also offer native structured reporting and workflow capabilities that increasingly compete with specialty mammography software at large health systems.

TypeEmerging player
Description

Volpara (acquired by Lunit) provides AI-driven breast density, risk, and reporting software to breast imaging centers. It overlaps with MagView's Luminary Risk module and is an emerging AI-native competitor with a cloud-first architecture.

9MRS Systems
TypeDirect peer
Description

MRS Systems (Mammography Reporting System) is a long-standing direct competitor offering structured mammography reporting, patient tracking, and breast center workflow software—overlapping with MagView's tracking and reporting modules.

TypeOthers
Description

Nuance's PowerScribe dictation platform is integrated by MagView for radiology reporting, but Microsoft/Nuance also offers broader radiology reporting and structured reporting capabilities that could expand into the mammography reporting niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MagView

Mammography Information Systems / Breast Imaging Workflow Softwaremagview.com

MagView is a privately held mammography information system software company founded in 1990 that serves over 2,500 U.S. breast imaging facilities with workflow, reporting, risk assessment, and MQSA compliance tools, including the Luminary Risk module with FDA-authorized AI.

What MagView does

MagView is a privately held mammography information system (MIS) software company founded in 1990 and originally developed for the American College of Radiology as the first BI-RADS structured reporting system. The company provides a modular software platform for U.S. breast imaging centers covering patient tracking, structured radiology reporting, MQSA compliance, workflow automation, patient navigation, and breast cancer risk assessment. Its core architecture combines the MagView MIS platform with the proprietary MagLink integration suite (supporting HL7, DICOM, and web APIs), the MagTAC interface monitor, and the Luminary Risk module for high-risk screening, which integrates the Tyrer-Cuzick v8.0 (IBIS) risk model alongside the FDA-authorized Clairity Breast AI image-based risk assessment and Myriad Genetics' hereditary cancer testing. MagView serves over 2,500 breast imaging facilities in the United States, with stated penetration of approximately 50% of the top 25 cancer hospitals, and is the only vendor with full NQMBC 2.0 certified software.

The company operates an enterprise direct-sales go-to-market motion with "Request a Demo" CTAs and quote-based pricing, targeting cancer centers, academic medical centers, large health systems, outpatient imaging providers, VA hospitals, and private radiology practices. Revenue is generated primarily through annual subscription licenses for the core MIS and modular add-ons, supplemented by implementation, configuration, training, and integration professional services. Notable named customers include CARTI Cancer Center, University of Virginia, MemorialCare Health System, SimonMed Imaging, Rayus Radiology, Houston Methodist, Penn State Health, Denver Health, Emory Winship Cancer Institute, and Steinberg Diagnostic Medical Imaging (SDMI). Long-standing technology partnerships include Hologic (co-developer of the Unifi EQUIP quality compliance software), Epic, Nuance, and the National Consortium of Breast Centers (NCoBC), and recent strategic collaborations include Clairity and Myriad Genetics to deliver an integrated AI and genetic risk assessment platform launched in November 2025.

The company is headquartered in Fulton, Maryland, employs 51-100 people, and is privately held with no disclosed parent company, outside investors, or funding rounds. MagView is also beginning to extend beyond breast imaging with a referenced Lung Screening offering (lungview.com), indicating modest adjacent-vertical expansion.

MagView firmographics

Firmographics
Name
MagView
Legal name
MagView
Website
https://magview.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
51–100 employees
Short description
MagView is a privately held mammography information system software company founded in 1990 that serves over 2,500 U.S. breast imaging facilities with workflow, reporting, risk assessment, and MQSA compliance tools, including the Luminary Risk module with FDA-authorized AI.
Ownership category
akta.pro rank

MagView industry classification

Industry
Product category
Mammography Information Systems / Breast Imaging Workflow Software
NAICS
Software Publishers (513210), Software Publishers (5132)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Mammography information systems
  • Breast imaging workflow software
  • BI-RADS structured reporting
  • MQSA compliance software
  • Breast cancer risk assessment

Where MagView is headquartered

Location

Headquarters

HQ city
Fulton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MagView business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

  1. Mammography Information System Software Licenses: MagView provides mammography tracking and reporting software to breast imaging centers, likely through annual or multi-year software licenses with implementation and support services included.
  2. Risk Assessment Software (Luminary Risk): High-risk breast cancer screening software sold to imaging facilities and healthcare providers for personalized risk assessment and patient management.
  3. Professional Services and Implementation: Implementation, configuration, and training services for breast imaging facilities deploying MagView software solutions.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise Healthcare Software - Quote-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

MagView product offering

Product offering

Core offering

MagView sells a mammography information system (MIS) software platform that helps breast imaging centers automate patient tracking, perform BI-RADS structured radiology reporting, manage MQSA compliance, run patient navigation, and conduct high-risk breast cancer risk assessment via its Luminary Risk module. The platform is sold primarily through direct enterprise sales to U.S. breast imaging centers, cancer centers, hospital systems, and radiology practices on a subscription/annual license basis, with implementation and support services included.

Product overview

MagView is a mammography information system (MIS) — a comprehensive, modular software platform for breast imaging centers. The core MagView platform provides patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics, upon which specialized modules are built. Key modules include: Mammography Tracking Software (automated patient tracking and follow-up), Radiology Reporting Software (BI-RADS structured and dictation-based reporting), Workflow Solutions (TechPad, patient experience tools), Compliance & Analytics (MQSA compliance), and Patient Navigation (care continuum tracking). The product suite is anchored by Luminary Risk — MagView's breast cancer risk assessment platform that integrates Tyrer-Cuzick and other risk models, and which now incorporates Clairity Breast (FDA-authorized AI image-based risk assessment) and connects to Myriad Genetics MyRisk hereditary cancer testing. A free online Tyrer-Cuzick Risk Calculator is also offered for patient-facing use. The platform serves more than 2,500 facilities across the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • Luminary Risk: High-risk breast cancer screening software for identifying and managing high-risk patients with support for unique workflows and facilities of any size.
  • MagView TechPad
  • MagLink
  • MagTAC

Products and services

  • MagView Mammography Information System Core mammography information system (MIS) platform for breast imaging centers providing patient tracking, mammography reporting, workflow automation, MQSA compliance, and analytics. Sold to U.S. breast imaging centers, cancer centers, and radiology practices via direct enterprise sales.
  • Luminary Risk High-risk breast cancer risk assessment platform integrating the Tyrer-Cuzick v8.0 (IBIS) risk model and Clairity Breast AI image-based risk assessment, with automated risk scoring, care pathway recommendations, and patient communication. Available in two versions: Luminary Risk for Breast Imaging and Luminary Risk for Providing Physicians.
  • Clairity Breast AI Image-Based Risk Assessment First and only FDA-authorized AI image-based breast cancer risk assessment that analyzes mammogram images to estimate a woman's five-year risk of developing breast cancer, now natively available within the Luminary Risk workflow software for breast imaging facilities.
  • Tyrer-Cuzick (IBIS) Risk Calculator Online breast cancer risk assessment tool using the Tyrer-Cuzick v8 (IBIS) risk model that estimates a patient's chance of developing breast cancer based on personal and family health history. Free non-clinical version for patients; clinical licenses available for facilities.
  • Mammography Tracking Software Automated patient tracking module that ensures no patient falls through the cracks with automated lay letters, reminders, and actionable reports. Includes automated BI-RADS, breast density, risk score, and recommendation extraction from dictated reports and MQSA compliance tracking. Sold to breast imaging centers as part of the MagView platform.
  • Radiology Reporting Software Flexible BI-RADS reporting module for breast radiologists with one-click negatives for screening mammograms, smart data capture from dictated reports, voice dictation integration, and full patient visibility including risk scores and history. Sold as part of the MagView platform.
  • Workflow Solutions Comprehensive breast imaging facility workflow solution including TechPad mobile workstation, integrated history collection, patient status board, advanced breast diagram, and integrations with EMR, RIS, PACS, and dictation systems. Sold to breast imaging facilities.
  • Compliance & Analytics MQSA compliance and analytics module that streamlines certification and compliance for breast imaging centers. Includes quality assurance dashboard, audit support, document management, real-time alerts, built-in MQSA reporting tools, outcome statistics calculations, and automated oversight of the EQUIP process. Sold to breast imaging facilities.
  • Patient Navigation Cancer patient navigation system that tracks patients through the continuum of care from imaging through treatment and beyond. Features user-defined navigation worklists, automated reminders, overdue follow-up flags, integrated imaging and pathology results, and customizable stages based on NCBC Navigation Matrix. Sold to breast centers.
  • Patient Experience Tools Suite of patient-facing tools including automated text messaging reminders, Patient History Portal (HIPAA-compliant online pre-visit questionnaires), Patient Tablet Module (in-office electronic forms with 95% adoption at some facilities), and Patient Results Portal (HIPAA-compliant access to lay letters). Sold to breast imaging centers.
  • TechPad Mobile Workstation Mobile technologist workflow tool that untethers technologists from desktop workstations, allowing them to move freely with patients, receive instant radiologist feedback, update patient status immediately, and reduce waiting time. Sold to breast imaging facilities.
  • MagLink Integration Suite First and only vendor-created integration suite enabling complex workflows via HL7, DICOM, and web APIs. Custom-written interfaces enable seamless connection with EHR, RIS, PACS, dictation systems, and other breast imaging technology systems. Sold as part of the MagView platform.
  • MagTAC Interface Monitor Real-time monitoring system that verifies proper functioning of database and interfaces, promptly alerting support team for minimal interface downtimes. Sold as part of the MagView platform to breast imaging facilities.
  • Integrated AI and Genetic Risk Platform Unified AI and genetic risk assessment platform combining Clairity Breast AI image-based risk assessment, Myriad's MyRisk Hereditary Cancer Test with RiskScore, and MagView's Luminary Risk workflow software for comprehensive personalized breast cancer risk assessment. Available through MagView's platform to 2,500+ U.S. breast imaging facilities.

Quantifiable outcome

  • Over 2,500 breast imaging facilities rely on MagView software
  • +3 more outcomes

Companies that use MagView

Customer profile

Named customers12 records

Segments5 records

Ideal customer profiles3 records

MagView technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability4 records

Feature13 records

MagView partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Myriad GeneticscoreTechnology or Integration · 25 November 2025Strategic collaboration to integrate Myriad's genetic testing capabilities (MyRisk Hereditary Cancer Test with RiskScore) with MagView's Luminary Risk platform for comprehensive breast cancer risk assessment. The integrated platform combines Clairity Breast AI image-based risk, Myriad's genetic testing, and MagView's workflow software into a unified tool for personalized breast health management.
  • ClairitycoreTechnology or Integration · 25 November 2025Integration partnership to bring Clairity Breast, the first and only FDA-authorized AI image-based breast cancer risk assessment, into MagView's Luminary Risk platform. Clairity Breast analyzes mammogram images to estimate five-year breast cancer risk, identifying high-risk women who may be missed by traditional models.
  • Know Your Lemons FoundationminorGTM or Marketing Partner · 5 November 2025Partnership to help breast centers improve screening rates by combining MagView's workflow solutions with Know Your Lemons' innovative breast health education using a simple, lemon-based visual system to teach signs of breast cancer.
  • HologiccoreTechnology or Integration · 1 January 2019Long-standing tight integration partnership with Hologic, leaders in breast imaging technology. Jointly developed the award-winning Unifi EQUIP software solution released in 2019 for mammography quality compliance.
  • Epic (EHR Integration)coreTechnology or IntegrationIntegration partnership enabling seamless data exchange between MagView's mammography software and Epic's electronic health record system, commonly used by many breast centers.
  • American College of Radiology (ACR)coreStrategic or Co-development PartnerMagView was originally founded by the ACR and developed as the first BI-RADS structured reporting system. Ongoing collaboration for MQSA compliance, BI-RADS standards, and breast imaging excellence.
  • DNA Visit (Genetic Counseling)minorChannel Partner/ Reseller/ DistributorVirtual care partnership providing patients access to board-certified genetic counselors from DNA Visit for hereditary cancer testing consultation through MagView's patient portal.
  • National Consortium of Breast Centers (NCoBC)coreStrategic or Co-development PartnerNCoBC elected MagView to lead development of the NQMBC 2.0 Vendor Certification Program. MagView is the first and remains the only certified software supporting NQMBC 2.0.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

MagView competitors and assessment

Company assessment

Broad incumbents

  • Hologic: Hologic is a leading breast imaging hardware OEM and a strategic partner of MagView (co-developed Unifi EQUIP). As a broad incumbent, it offers SecurView diagnostic workstations and increasingly competes at the workflow layer via its own mammography software stack.
  • Epic Systems (Beaker): Epic's Beaker LIS and imaging modules are integrated with MagView via MagLink but also offer native structured reporting and workflow capabilities that increasingly compete with specialty mammography software at large health systems.

Emerging players

  • Koios Medical: Koios Medical offers AI decision-support for breast and thyroid ultrasound, with breast applications that overlap with MagView's risk-assessment and reporting modules for downstream supplemental imaging.
  • CureMetrix: CureMetrix develops AI-based mammography CADt and triage algorithms that integrate into breast imaging reporting workflows. It competes at the AI image-based risk and detection layer that MagView addresses via Clairity.
  • iCAD: iCAD offers ProFound AI for breast cancer detection and risk assessment, integrating into mammography reporting workflows. It competes with MagView's Clairity-integrated Luminary Risk on AI image-based risk and detection.
  • Densitas: Densitas provides AI-driven breast density assessment and quality assurance tools integrated with mammography reporting workflows. It overlaps with MagView's density extraction and risk modules and represents a more specialized AI-native competitor.
  • Volpara Health Technologies (Lunit): Volpara (acquired by Lunit) provides AI-driven breast density, risk, and reporting software to breast imaging centers. It overlaps with MagView's Luminary Risk module and is an emerging AI-native competitor with a cloud-first architecture.

Direct peers

  • PenRad Technologies: PenRad is a direct competitor to MagView, providing mammography reporting, patient tracking, and MQSA/EQUIP compliance software to breast imaging centers across the United States. It overlaps most closely with MagView's core MIS and reporting modules.
  • MRS Systems: MRS Systems (Mammography Reporting System) is a long-standing direct competitor offering structured mammography reporting, patient tracking, and breast center workflow software—overlapping with MagView's tracking and reporting modules.

Others

  • Nuance (Microsoft) PowerScribe: Nuance's PowerScribe dictation platform is integrated by MagView for radiology reporting, but Microsoft/Nuance also offers broader radiology reporting and structured reporting capabilities that could expand into the mammography reporting niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MagView social profiles

Digital presence

MagView compliance and trust

Trust signal

Compliance1 record

MagView financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MagView leadership team

Management profile

Number of profiles

MagView funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MagView M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MagView

What does MagView do?

MagView sells a mammography information system (MIS) software platform that helps breast imaging centers automate patient tracking, perform BI-RADS structured radiology reporting, manage MQSA compliance, run patient navigation, and conduct high-risk breast cancer risk assessment via its Luminary Risk module. The platform is sold primarily through direct enterprise sales to U.S. breast imaging centers, cancer centers, hospital systems, and radiology practices on a subscription/annual license basis, with implementation and support services included.

Is MagView a public or private company?

MagView is a private company. It is classified as management employee owned and is currently operating.

When was MagView founded?

MagView was founded in 1990. It employs 51 to 100 people.

Where is MagView based?

MagView is headquartered in Fulton, United States, in the North America region.

How does MagView make money?

Three revenue lines are on record. Mammography Information System Software Licenses are the primary driver. The others are risk Assessment Software (Luminary Risk) and professional Services and Implementation.

Who are MagView's main competitors?

Broad incumbents on record are Hologic and Epic Systems (Beaker). Emerging players are Koios Medical, CureMetrix, iCAD, Densitas and Volpara Health Technologies (Lunit). Direct peers are PenRad Technologies and MRS Systems. Nuance (Microsoft) PowerScribe is listed as an others.

Does MagView have an API?

No public API is recorded for MagView.

What industry is MagView in?

MagView's product category is Mammography Information Systems / Breast Imaging Workflow Software. Its primary akta.pro industry code is HLACALAL, Quality, Peer Review & Compliance Tools (MQSA/ACR/QA), with a secondary code of HLACABAM, Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity). Its NAICS code is 513210 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LinkedInBrendan O'Leary - Kilo CodeBrendan O'Leary joined Magview and has expanded the company to twice its size. He improved incident management, process management, and customer loyalty, and fosters a collaborative environment. He is recommended as a dedicated, reliable, and knowledgeable executive.Simply Wall StMYGN: Sector Fundamentals And New Diagnostics Partnerships Will Support A More Constructive OutlookAnalysts have lowered their Myriad Genetics price target to $7 from $9, reflecting increased risk assumptions around revenue growth, profit margins, and future P/E multiples, though they maintain a Hold rating citing solid diagnostics sector fundamentals. The company outlined a March 2026 launch for its Precise MRD ctDNA assay and projected full-year 2026 revenue of $860-880 million. Myriad also announced new partnerships including a Zydus Lifesciences agreement to introduce hereditary cancer tests in India, and a collaboration with Clairity and MagView for integrated breast cancer risk assessment in the U.S.The Manila TimesClairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast HealthClairity, Myriad Genetics, and MagView announced a joint collaboration to integrate breast cancer risk assessment tools. The platform combines Myriad's MyRisk Hereditary Cancer Test with Clairity's AI-powered Clairity Breast, which estimates five-year breast cancer risk from routine mammograms. The integration aims to enable earlier, personalized interventions without adding administrative burdens.GlobeNewswireClairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast HealthClairity, Myriad Genetics, and MagView announced a joint collaboration to create an integrated AI and genetic risk platform for personalized breast health screening. The platform combines Clairity Breast (FDA-authorized AI for mammogram-based risk assessment), Myriad's MyRisk Hereditary Cancer Test with RiskScore (genetic and clinical risk scoring), and MagView's Luminary Risk workflow platform to give clinicians a unified view of breast cancer risk. The integration aims to address gaps in current breast cancer risk assessment by merging genotype and phenotype data without adding administrative burden for clinicians.Stock TitanMyriad Genetics, Clairity & MagView Launch Breast Risk PlatformClairity, Myriad Genetics, and MagView announced a joint collaboration to launch an integrated AI and genetic risk platform for personalized breast health. The solution combines Clairity's FDA-authorized mammogram-based risk assessment with Myriad's hereditary cancer testing within MagView's software workflow. This integration aims to provide clinicians with actionable data to enable earlier interventions for women at high risk of breast cancer.MarketScreenerMyriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk AssessmentMyriad Genetics has collaborated with Clairity and MagView to launch an AI-powered platform designed for breast cancer risk assessment. This partnership aims to integrate advanced artificial intelligence into genetic testing workflows to improve the accuracy and efficiency of patient care. The initiative represents a strategic expansion of Myriad's capabilities in oncology and precision medicine.MarketScreenerClairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast HealthClairity, Myriad Genetics, and MagView announced a joint collaboration to launch an integrated AI and genetic risk platform for personalized breast health assessment. The platform combines Clairity Breast (FDA-authorized AI for estimating five-year breast cancer risk from mammograms), Myriad Genetics' MyRisk Hereditary Cancer Test with RiskScore, and MagView's Luminary Risk platform to provide clinicians with an integrated view of genotype and phenotype data. The unified tool is designed to identify high-risk women earlier and improve workflow efficiency across breast imaging centers in the United States.YahooClairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast HealthClairity, Myriad Genetics, and MagView announced a joint collaboration on November 25, 2025, to create an integrated AI and genetic risk platform for personalized breast cancer risk assessment. The platform combines Clairity Breast (FDA-authorized AI that estimates five-year breast cancer risk from routine mammograms), Myriad's MyRisk Hereditary Cancer Test with RiskScore, and MagView's Luminary Risk workflow software into a single unified tool. This integration, accessible through MagView's platform used by more than 2,500 facilities across the United States, aims to provide clinicians with a more complete view of risk than age and family history alone, enabling earlier and more personalized breast cancer interventions.PR NewswireMagView Announces New Look with Branding RefreshMagView, a provider of breast center information management solutions, announced a new branding initiative including a refreshed logo that will begin rolling out this month. The new design retains the breast cancer ribbon and signature purple color but incorporates them in a new way to reflect the company's evolution in the breast imaging market. The company, which has served breast centers for three decades and now supports over 2,500 facilities across the U.S., stated that customers can expect the same quality software and workflow expertise under the new brand identity.